Healthcare entity

Gene Solutions

Company

Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention American Society of Clinical Oncology (ASCO), the most common co-covered peer. Each carries 3 original sources on average. We currently track 1 Healthcare story that mention Gene Solutions, all published on July 22, 2026.

Last mentioned: Jul 22, 2026

Entity pulse

Recent coverage · Gene Solutions

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Gene Solutions

Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention American Society of Clinical Oncology (ASCO), the most common co-covered peer. Each carries 3 original sources on average. We currently track 1 Healthcare story that mention Gene Solutions, all published on July 22, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Gene Solutions. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Global Milestone Announcement

    Gene Solutions issues press release detailing ASCO recognition, FDA designation, and IPO plans, marking a turning point for the company.

  2. FDA Breakthrough Device Designation

    The U.S. FDA grants Breakthrough Device Designation to SPOT-MAS 10, acknowledging its potential to address unmet needs in cancer screening.

  3. ASCO Breakthrough 2026

    Gene Solutions presents interim real-world data from 84,145 asymptomatic individuals for SPOT-MAS 10 at the ASCO Breakthrough conference in Singapore.

Stories mentioning Gene Solutions 1

Gene Solutions is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.